The rise of Clostridium difficile infection in lung transplant recipients in the modern era

Janet T Lee, Marshall I Hertz, Jordan M Dunitz, Rosemary F Kelly, Jonathan D'Cunha, Bryan A. Whitson, Sara J Shumway

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Purpose: Clostridium difficile infection (CDI) rates have been rising in recent years. We aimed to characterize CDI in lung transplant recipients in the modern era and hypothesized that CDI would increase the mortality risk. Methods: We performed a retrospective chart review of patients undergoing transplantation at our center from 1/2006 to 7/2011. Attributes of CDI+ and CDI- groups were compared using Student's t- and chi-square tests (α = 0.05). Multivariate Cox proportional hazard models were used to control for confounding factors. Results: Overall CDI incidence was 22.5%. Seven of 151 patients (4.6%) developed CDI during the initial hospitalization after transplantation (mean time 10.6 ± 6 d) while 27 patients (19.7%) developed CDI after discharge (mean time 467 ± 471 d). Incidence rate was 224.6 cases/100 000 patient-days compared to 110 cases/100 000 patient-days (rate for entire hospital). CDI was not predictive of mortality (HR 2.06, 95% CI 0.94-4.52). Conclusion: CDI rates in lung transplant recipients are high in the modern era. No risk factors for CDI were identified. Although not statistically significant, CDI+ patients had a higher risk of death. The economic burden of CDI and trend toward worse outcomes for CDI patients have important implications for post-operative surveillance of CDI-related complications and need for CDI prophylaxis.

Original languageEnglish (US)
Pages (from-to)303-310
Number of pages8
JournalClinical Transplantation
Volume27
Issue number2
DOIs
StatePublished - Mar 1 2013

Fingerprint

Clostridium Infections
Clostridium difficile
Lung
Transplant Recipients
Transplantation
Mortality
Incidence

Keywords

  • Clostridium difficile
  • Infection
  • Lung transplantation
  • Thoracic surgery

Cite this

The rise of Clostridium difficile infection in lung transplant recipients in the modern era. / Lee, Janet T; Hertz, Marshall I; Dunitz, Jordan M; Kelly, Rosemary F; D'Cunha, Jonathan; Whitson, Bryan A.; Shumway, Sara J.

In: Clinical Transplantation, Vol. 27, No. 2, 01.03.2013, p. 303-310.

Research output: Contribution to journalArticle

@article{c30a9371c8fb4b16bbcc669a494a72a0,
title = "The rise of Clostridium difficile infection in lung transplant recipients in the modern era",
abstract = "Purpose: Clostridium difficile infection (CDI) rates have been rising in recent years. We aimed to characterize CDI in lung transplant recipients in the modern era and hypothesized that CDI would increase the mortality risk. Methods: We performed a retrospective chart review of patients undergoing transplantation at our center from 1/2006 to 7/2011. Attributes of CDI+ and CDI- groups were compared using Student's t- and chi-square tests (α = 0.05). Multivariate Cox proportional hazard models were used to control for confounding factors. Results: Overall CDI incidence was 22.5{\%}. Seven of 151 patients (4.6{\%}) developed CDI during the initial hospitalization after transplantation (mean time 10.6 ± 6 d) while 27 patients (19.7{\%}) developed CDI after discharge (mean time 467 ± 471 d). Incidence rate was 224.6 cases/100 000 patient-days compared to 110 cases/100 000 patient-days (rate for entire hospital). CDI was not predictive of mortality (HR 2.06, 95{\%} CI 0.94-4.52). Conclusion: CDI rates in lung transplant recipients are high in the modern era. No risk factors for CDI were identified. Although not statistically significant, CDI+ patients had a higher risk of death. The economic burden of CDI and trend toward worse outcomes for CDI patients have important implications for post-operative surveillance of CDI-related complications and need for CDI prophylaxis.",
keywords = "Clostridium difficile, Infection, Lung transplantation, Thoracic surgery",
author = "Lee, {Janet T} and Hertz, {Marshall I} and Dunitz, {Jordan M} and Kelly, {Rosemary F} and Jonathan D'Cunha and Whitson, {Bryan A.} and Shumway, {Sara J}",
year = "2013",
month = "3",
day = "1",
doi = "10.1111/ctr.12064",
language = "English (US)",
volume = "27",
pages = "303--310",
journal = "Clinical Transplantation",
issn = "0902-0063",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - The rise of Clostridium difficile infection in lung transplant recipients in the modern era

AU - Lee, Janet T

AU - Hertz, Marshall I

AU - Dunitz, Jordan M

AU - Kelly, Rosemary F

AU - D'Cunha, Jonathan

AU - Whitson, Bryan A.

AU - Shumway, Sara J

PY - 2013/3/1

Y1 - 2013/3/1

N2 - Purpose: Clostridium difficile infection (CDI) rates have been rising in recent years. We aimed to characterize CDI in lung transplant recipients in the modern era and hypothesized that CDI would increase the mortality risk. Methods: We performed a retrospective chart review of patients undergoing transplantation at our center from 1/2006 to 7/2011. Attributes of CDI+ and CDI- groups were compared using Student's t- and chi-square tests (α = 0.05). Multivariate Cox proportional hazard models were used to control for confounding factors. Results: Overall CDI incidence was 22.5%. Seven of 151 patients (4.6%) developed CDI during the initial hospitalization after transplantation (mean time 10.6 ± 6 d) while 27 patients (19.7%) developed CDI after discharge (mean time 467 ± 471 d). Incidence rate was 224.6 cases/100 000 patient-days compared to 110 cases/100 000 patient-days (rate for entire hospital). CDI was not predictive of mortality (HR 2.06, 95% CI 0.94-4.52). Conclusion: CDI rates in lung transplant recipients are high in the modern era. No risk factors for CDI were identified. Although not statistically significant, CDI+ patients had a higher risk of death. The economic burden of CDI and trend toward worse outcomes for CDI patients have important implications for post-operative surveillance of CDI-related complications and need for CDI prophylaxis.

AB - Purpose: Clostridium difficile infection (CDI) rates have been rising in recent years. We aimed to characterize CDI in lung transplant recipients in the modern era and hypothesized that CDI would increase the mortality risk. Methods: We performed a retrospective chart review of patients undergoing transplantation at our center from 1/2006 to 7/2011. Attributes of CDI+ and CDI- groups were compared using Student's t- and chi-square tests (α = 0.05). Multivariate Cox proportional hazard models were used to control for confounding factors. Results: Overall CDI incidence was 22.5%. Seven of 151 patients (4.6%) developed CDI during the initial hospitalization after transplantation (mean time 10.6 ± 6 d) while 27 patients (19.7%) developed CDI after discharge (mean time 467 ± 471 d). Incidence rate was 224.6 cases/100 000 patient-days compared to 110 cases/100 000 patient-days (rate for entire hospital). CDI was not predictive of mortality (HR 2.06, 95% CI 0.94-4.52). Conclusion: CDI rates in lung transplant recipients are high in the modern era. No risk factors for CDI were identified. Although not statistically significant, CDI+ patients had a higher risk of death. The economic burden of CDI and trend toward worse outcomes for CDI patients have important implications for post-operative surveillance of CDI-related complications and need for CDI prophylaxis.

KW - Clostridium difficile

KW - Infection

KW - Lung transplantation

KW - Thoracic surgery

UR - http://www.scopus.com/inward/record.url?scp=84876070817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876070817&partnerID=8YFLogxK

U2 - 10.1111/ctr.12064

DO - 10.1111/ctr.12064

M3 - Article

C2 - 23316931

AN - SCOPUS:84876070817

VL - 27

SP - 303

EP - 310

JO - Clinical Transplantation

JF - Clinical Transplantation

SN - 0902-0063

IS - 2

ER -